The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ultragenyx Pharmaceutical Inc(NASDAQ:RARE) 
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. Its biologic products include Crysvita (burosumab), an antibod...
Website: http://www.ultragenyx.com
Founded: 2010
Full Time Employees: 740
Sector: Healthcare
Industry: Biotechnology
Ultragenyx Pharmaceutical Days Payable Outstanding ttm (DPO)
Ultragenyx Pharmaceutical Days Receivable Outstanding ttm (DSO)
Ultragenyx Pharmaceutical Days Inventory Outstanding ttm (DIO)
Ultragenyx Pharmaceutical Op Cashflow Per Share ttm
Ultragenyx Pharmaceutical Free Cashflow Per Share ttm
Ultragenyx Pharmaceutical Cash Per Share ttm
Ultragenyx Pharmaceutical P/S ratio ttm
Ultragenyx Pharmaceutical (GAAP) P/E ratio ttm
Ultragenyx Pharmaceutical P/B ratio ttm
No extra charts and metrics for this ticker.